The US Food and Drug Administration has approved the first test that identifies the genotype, or strain, of the hepatitis C virus which is present in individuals with chronic HCV infection. It has been manufactured by Abbott Molecular Inc. ---Subscribe to MedNous to access this article--- Regulation & Policy
